95 filings
Page 4 of 5
6-K
szadc8
7 Dec 20
Current report (foreign)
10:14am
6-K
t8ikm54xaf6ie
6 Nov 20
ERYTECH Announces Abstract with Results from Eryaspase
9:24am
6-K
tfvmj0
3 Nov 20
ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
4:33pm
6-K
mcukh e8yw
22 Sep 20
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
12:00am
6-K
2ope 22sjc631i
21 Sep 20
I. Certification of the Person Responsible for the Half-year Financial Report
6:09am
6-K
te8ol8t
15 Sep 20
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
7:32am
6-K
8bei k5vlnxx
26 Jun 20
Current report (foreign)
5:10pm
6-K
xhz21l
25 Jun 20
Current report (foreign)
4:31pm
6-K
lnda1i1 4pvm
9 Jun 20
ERYTECH Provides Update on Phase 2 Investigator
4:11pm
6-K
htch271fusclp193
2 Jun 20
ERYTECH Announces Poster Presentations
5:07pm
6-K
6h73g5hzkda
26 May 20
Erytech’s Combined Shareholders’ Meeting
4:40pm
6-K
iqy5q
8 May 20
ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020
4:08pm
6-K
59ykvtkjn01hipv u6y
30 Apr 20
ERYTECH Granted U.S. FDA Fast Track Designation
7:59am
6-K
ni0wpx7ejvp2ccq8myyh
21 Apr 20
ERYTECH Provides Update on theTRYbeCA-1
7:06am
6-K
usjk38
17 Mar 20
ERYTECH Announces the Appointment of
4:25pm
6-K
iuvoaxvuoxmmf
6 Feb 20
Current report (foreign)
4:16pm
6-K
kqyr h5smr101r3aqb
8 Nov 19
ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019
8:44am
6-K
gf37kvhpftl3 70
26 Sep 19
Half-year Financial Report
4:14pm
6-K
2ygpukp
18 Sep 19
Reports Financial Results for the First Half of 2019
9:30am
6-K
zm6w0plc6sj8o kfk
16 Jul 19
ERYTECH Pharma Reports Voting Results from Annual
4:27pm